105 related articles for article (PubMed ID: 22079253)
1. Discovery of selective glucocorticoid receptor modulator MK-5932.
Bungard CJ; Hartman GD; Manikowski JJ; Perkins JJ; Bai C; Brandish PE; Euler DH; Hershey JC; Schmidt A; Fang Y; Norcross RT; Rushmore TH; Thompson CD; Meissner RS
Bioorg Med Chem; 2011 Dec; 19(24):7374-86. PubMed ID: 22079253
[TBL] [Abstract][Full Text] [Related]
2. The preclinical efficacy, selectivity and pharmacologic profile of MK-5932, an insulin-sparing selective glucocorticoid receptor modulator.
Brandish PE; Anderson K; Baltus GA; Bai C; Bungard CJ; Bunting P; Byford A; Chiu CS; Cicmil M; Corcoran H; Euler D; Fisher JE; Gambone C; Hasbun-Manning M; Kuklin N; Landis E; Lifsted TQ; McElwee-Witmer S; McIntosh IS; Meissner RS; Miao J; Mitchell HJ; Musselman A; Schmidt A; Shin J; Szczerba P; Thompson CD; Tribouley C; Vogel RL; Warrier S; Hershey JC
Eur J Pharmacol; 2014 Feb; 724():102-11. PubMed ID: 24374007
[TBL] [Abstract][Full Text] [Related]
3. Discovery of quinolines as selective glucocorticoid receptor agonists.
Jaroch S; Berger M; Huwe C; Krolikiewicz K; Rehwinkel H; Schäcke H; Schmees N; Skuballa W
Bioorg Med Chem Lett; 2010 Oct; 20(19):5835-8. PubMed ID: 20727743
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a potent and dissociated non-steroidal glucocorticoid receptor agonist containing an alkyl carbinol pharmacophore.
Razavi H; Riether D; Harcken C; Bentzien J; Dinallo RM; Souza D; Nelson RM; Kukulka A; Fadra-Khan TN; Pack EJ; Zuvela-Jelaska L; Pelletier J; Panzenbeck M; Torcellini CA; Proudfoot JR; Nabozny GH; Thomson DS
Bioorg Med Chem Lett; 2014 Apr; 24(8):1934-40. PubMed ID: 24656565
[TBL] [Abstract][Full Text] [Related]
5. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.
Schäcke H; Schottelius A; Döcke WD; Strehlke P; Jaroch S; Schmees N; Rehwinkel H; Hennekes H; Asadullah K
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):227-32. PubMed ID: 14694204
[TBL] [Abstract][Full Text] [Related]
6. Discovery of new selective glucocorticoid receptor agonist leads.
Berger M; Rehwinkel H; Schmees N; Schäcke H; Edman K; Wissler L; Reichel A; Jaroch S
Bioorg Med Chem Lett; 2017 Feb; 27(3):437-442. PubMed ID: 28043796
[TBL] [Abstract][Full Text] [Related]
7. Drug insight: selective agonists and antagonists of the glucocorticoid receptor.
McMaster A; Ray DW
Nat Clin Pract Endocrinol Metab; 2008 Feb; 4(2):91-101. PubMed ID: 18212811
[TBL] [Abstract][Full Text] [Related]
8. 5α-Reduced glucocorticoids: a story of natural selection.
Nixon M; Upreti R; Andrew R
J Endocrinol; 2012 Feb; 212(2):111-27. PubMed ID: 21903862
[TBL] [Abstract][Full Text] [Related]
9. Function-regulating pharmacophores in a sulfonamide class of glucocorticoid receptor agonists.
Kuzmich D; Bentzien J; Betageri R; DiSalvo D; Fadra-Khan T; Harcken C; Kukulka A; Nabozny G; Nelson R; Pack E; Souza D; Thomson D
Bioorg Med Chem Lett; 2013 Dec; 23(24):6640-4. PubMed ID: 24215891
[TBL] [Abstract][Full Text] [Related]
10. Beneficial pharmacological effects of selective glucocorticoid receptor agonist in external eye diseases.
Kato M; Hagiwara Y; Oda T; Imamura-Takai M; Aono H; Nakamura M
J Ocul Pharmacol Ther; 2011 Aug; 27(4):353-60. PubMed ID: 21574866
[TBL] [Abstract][Full Text] [Related]
11. 5-Functionalized indazoles as glucocorticoid receptor agonists.
Bai M; Carr G; Deorazio RJ; Friedrich TD; Dobritsa S; Fitzpatrick K; Guzzo PR; Kitchen DB; Lynch MA; Peace D; Sajad M; Usyatinsky A; Wolf MA
Bioorg Med Chem Lett; 2010 May; 20(10):3017-20. PubMed ID: 20427184
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Compound A--a selective activator of the glucocorticoid receptor with anti-inflammatory and anti-cancer activity.
Lesovaya E; Yemelyanov A; Swart AC; Swart P; Haegeman G; Budunova I
Oncotarget; 2015 Oct; 6(31):30730-44. PubMed ID: 26436695
[TBL] [Abstract][Full Text] [Related]
13. Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds.
Sundahl N; Bridelance J; Libert C; De Bosscher K; Beck IM
Pharmacol Ther; 2015 Aug; 152():28-41. PubMed ID: 25958032
[TBL] [Abstract][Full Text] [Related]
14. In vitro biotransformation of a novel antimalarial cysteine protease inhibitor in human liver microsomes.
Zhang Y; Guo X; Lin ET; Benet LZ
Pharmacology; 1999 Mar; 58(3):147-59. PubMed ID: 9925971
[TBL] [Abstract][Full Text] [Related]
15. [New developments in glucocorticoid therapy: selective glucocorticoid receptor agonists, nitrosteroids and liposomal glucocorticoids].
Huisman AM; Jacobs JW; Buttgereit F; Bijlsma JW
Ned Tijdschr Geneeskd; 2006 Mar; 150(9):476-80. PubMed ID: 16553045
[TBL] [Abstract][Full Text] [Related]
16. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation.
Vandevyver S; Dejager L; Tuckermann J; Libert C
Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile.
Ripa L; Edman K; Dearman M; Edenro G; Hendrickx R; Ullah V; Chang HF; Lepistö M; Chapman D; Geschwindner S; Wissler L; Svanberg P; Lawitz K; Malmberg J; Nikitidis A; Olsson RI; Bird J; Llinas A; Hegelund-Myrbäck T; Berger M; Thorne P; Harrison R; Köhler C; Drmota T
J Med Chem; 2018 Mar; 61(5):1785-1799. PubMed ID: 29424542
[TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal glucocorticoid agonists: tetrahydronaphthalenes with alternative steroidal A-ring mimetics possessing dissociated (transrepression/transactivation) efficacy selectivity.
Biggadike K; Boudjelal M; Clackers M; Coe DM; Demaine DA; Hardy GW; Humphreys D; Inglis GG; Johnston MJ; Jones HT; House D; Loiseau R; Needham D; Skone PA; Uings I; Veitch G; Weingarten GG; McLay IM; Macdonald SJ
J Med Chem; 2007 Dec; 50(26):6519-34. PubMed ID: 18038970
[TBL] [Abstract][Full Text] [Related]
19. Role of Glucocorticoid Receptor and Pregnane X Receptor in Dexamethasone Induction of Rat Hepatic Aryl Hydrocarbon Receptor Nuclear Translocator and NADPH-Cytochrome P450 Oxidoreductase.
Hunter SR; Vonk A; Mullen Grey AK; Riddick DS
Drug Metab Dispos; 2017 Feb; 45(2):118-129. PubMed ID: 27856527
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel dihydro-9,10-ethano-anthracene carboxamides as glucocorticoid receptor modulators.
Yang BV; Vaccaro W; Doweyko AM; Doweyko LM; Huynh T; Tortolani D; Nadler SG; McKay L; Somerville J; Holloway DA; Habte S; Weinstein DS; Barrish JC
Bioorg Med Chem Lett; 2009 Apr; 19(8):2139-43. PubMed ID: 19321341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
